These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 10999082

  • 1. A randomised control trial on sequential drug monotherapy versus conventional step care therapy in the treatment of mild to moderate hypertension.
    Jagadevan R, Cherian AM, Jeyaseelan L, Peter JV.
    J Assoc Physicians India; 1999 Feb; 47(2):173-6. PubMed ID: 10999082
    [Abstract] [Full Text] [Related]

  • 2. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Feb; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS.
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [Abstract] [Full Text] [Related]

  • 4. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.
    Mallion JM, Dutrey-Dupagne C, Vaur L, Genes N, Renault M, Elkik F, Baguet P, Boutelant S.
    J Hypertens; 1996 Jan; 14(1):137-44. PubMed ID: 12013487
    [Abstract] [Full Text] [Related]

  • 5. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 8. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [Abstract] [Full Text] [Related]

  • 9. [Shared decision-making with hypertensive patients. Results of an implementation in Germany].
    Deinzer A, Babel H, Veelken R, Kohnen R, Schmieder RE.
    Dtsch Med Wochenschr; 2006 Nov 17; 131(46):2592-6. PubMed ID: 17096305
    [Abstract] [Full Text] [Related]

  • 10. Clinical trial of benidipine in mild to moderate hypertension.
    Kalke S, Shah BV, Nair KG, Gala D, Sood OP, Bagati A.
    J Assoc Physicians India; 1999 Feb 17; 47(2):195-7. PubMed ID: 10999089
    [Abstract] [Full Text] [Related]

  • 11. An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension.
    Chowta KN, Chowta MN, Bhat P, Adhikari PM.
    J Assoc Physicians India; 2002 Oct 17; 50():1236-9. PubMed ID: 12568205
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER, Botero R, Octavio JA, Berrizbeitia ML, Mayorca E, Castro P, Miranda R, Valecillo E, Aroca G, Aza G, González M.
    Am J Ther; 2007 Oct 17; 14(2):140-6. PubMed ID: 17414581
    [Abstract] [Full Text] [Related]

  • 13. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 17; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA, Rizzoni D, DIMS II (Delapril-Indapamide Multicenter Study II).
    J Hum Hypertens; 2003 Feb 17; 17(2):139-46. PubMed ID: 12574793
    [Abstract] [Full Text] [Related]

  • 15. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
    Andreadis EA, Tsourous GI, Marakomichelakis GE, Katsanou PM, Fotia ME, Vassilopoulos CV, Diamantopoulos EJ.
    J Hum Hypertens; 2005 Jun 17; 19(6):491-6. PubMed ID: 15759025
    [Abstract] [Full Text] [Related]

  • 16. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 17; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 17. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 17; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of valsartan in patients with mild to moderate essential hypertension.
    Nouh MS, Halim SA.
    Saudi Med J; 2002 May 17; 23(5):521-5. PubMed ID: 12070572
    [Abstract] [Full Text] [Related]

  • 19. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 17; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 20. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.
    J Hum Hypertens; 2001 Dec 17; 15(12):841-8. PubMed ID: 11773986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.